David J. Einstein
@davidjeinstein.bsky.social
Disease Group Leader, BIDMC GU Medical Oncology, Dana-Farber/Harvard Cancer Center
Massachusetts Prostate Cancer Coalition annual virtual symposium starting in 1 hour!
masspcc.org/events/
masspcc.org/events/
Events
EVENTS
MPCC Events
MPCC Prostate Cancer Symposium Virtual Event
Friday, May 16, 8:30 a.m. – 11:15 a.m. ET
The 2025 Massachusetts Prostate Cancer Symposium — leading prostate cancer ...
masspcc.org
May 16, 2025 at 11:23 AM
Massachusetts Prostate Cancer Coalition annual virtual symposium starting in 1 hour!
masspcc.org/events/
masspcc.org/events/
All of prostate cancer in an hour! This Thursday, 8-9 EST
Harvard Medical Grand Rounds - Live Streaming
urldefense.com
March 4, 2025 at 5:53 PM
All of prostate cancer in an hour! This Thursday, 8-9 EST
Tonight at the Boston Prostate Cancer Support Group:
7-8 pm EST: Christie Klisz, NP on the role of NPs in the care team
Patient subgroups meet 6-7 pm
bostonprostatecancer.org for more information, and archives of prior presentations
7-8 pm EST: Christie Klisz, NP on the role of NPs in the care team
Patient subgroups meet 6-7 pm
bostonprostatecancer.org for more information, and archives of prior presentations
Boston Prostate Cancer Support Group
bostonprostatecancer.org
March 3, 2025 at 10:27 PM
Tonight at the Boston Prostate Cancer Support Group:
7-8 pm EST: Christie Klisz, NP on the role of NPs in the care team
Patient subgroups meet 6-7 pm
bostonprostatecancer.org for more information, and archives of prior presentations
7-8 pm EST: Christie Klisz, NP on the role of NPs in the care team
Patient subgroups meet 6-7 pm
bostonprostatecancer.org for more information, and archives of prior presentations
Reposted by David J. Einstein
Almost all guidelines recommend active surveillance for low and selected int risk #ProstateCancer
But no one tells you the IR pts that are safe… until now
Over 1500 pts, >10y mFU: absolute % pattern 4/5 has same MFS as GG1 ds
Ruben del Castillo presented at #GU25 & awarded @asco Award of Merit
But no one tells you the IR pts that are safe… until now
Over 1500 pts, >10y mFU: absolute % pattern 4/5 has same MFS as GG1 ds
Ruben del Castillo presented at #GU25 & awarded @asco Award of Merit
February 15, 2025 at 4:19 PM
Almost all guidelines recommend active surveillance for low and selected int risk #ProstateCancer
But no one tells you the IR pts that are safe… until now
Over 1500 pts, >10y mFU: absolute % pattern 4/5 has same MFS as GG1 ds
Ruben del Castillo presented at #GU25 & awarded @asco Award of Merit
But no one tells you the IR pts that are safe… until now
Over 1500 pts, >10y mFU: absolute % pattern 4/5 has same MFS as GG1 ds
Ruben del Castillo presented at #GU25 & awarded @asco Award of Merit
Patients with prostate cancer and those who care about them:
Join the Boston Prostate Cancer Support Group monthly Zoom meeting tonight!
Sign up at bostonprostatecancer.org.
Join the Boston Prostate Cancer Support Group monthly Zoom meeting tonight!
Sign up at bostonprostatecancer.org.
Boston Prostate Cancer Support Group
bostonprostatecancer.org
February 3, 2025 at 4:30 PM
Patients with prostate cancer and those who care about them:
Join the Boston Prostate Cancer Support Group monthly Zoom meeting tonight!
Sign up at bostonprostatecancer.org.
Join the Boston Prostate Cancer Support Group monthly Zoom meeting tonight!
Sign up at bostonprostatecancer.org.
Happy New Year, 12 hours ahead of EST!
January 1, 2025 at 12:57 AM
Happy New Year, 12 hours ahead of EST!
Exciting to see this out!
Androgen receptor drives polyamine synthesis creating a vulnerability for prostate cancer https://www.medrxiv.org/content/10.1101/2024.12.12.24318845v1
December 14, 2024 at 4:16 PM
Exciting to see this out!
Fascinating and well written! Reminiscent of a patient from our rapid autopsy cohort with targetable truncal driver but remarkable “dead-end” CNA-quiet subclones in the primary that fail to metastasize despite aggressive histology.
pubmed.ncbi.nlm.nih.gov/34568716/
pubmed.ncbi.nlm.nih.gov/34568716/
December 9, 2024 at 8:09 PM
Fascinating and well written! Reminiscent of a patient from our rapid autopsy cohort with targetable truncal driver but remarkable “dead-end” CNA-quiet subclones in the primary that fail to metastasize despite aggressive histology.
pubmed.ncbi.nlm.nih.gov/34568716/
pubmed.ncbi.nlm.nih.gov/34568716/
Beth Israel Deaconess/Dana-Farber Harvard Cancer Center is hiring a GU medical oncologist! Aside from all the usual reasons to come, every group member gets a birthday cake in clinic.
November 27, 2024 at 1:52 PM
Beth Israel Deaconess/Dana-Farber Harvard Cancer Center is hiring a GU medical oncologist! Aside from all the usual reasons to come, every group member gets a birthday cake in clinic.
